<DOC>
	<DOCNO>NCT00774436</DOCNO>
	<brief_summary>The purpose study find men , low-risk prostate , small amount cancer within prostate remove freezing , call Focal Cryoablation Cryotherapy .</brief_summary>
	<brief_title>Study Focal Cryoablation Low-Risk Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>A twostep consent process place patient enrol study . The twostep method necessary patient enrol need repeat transrectal biopsy meeting initial study requirement . The two step consent process would enroll patient consider focal cryotherapy initial part study ( QOL assessment baseline , PCA3 test , repeat biopsy ) ; deem eligible restaging biopsy would consent participate remainder study ( focal cryotherapy , QOL study , repeat biopsy 6 month efficacy , PCA3 test ) . First Step Enrollment Men â‰¥ 21 year age life expectancy estimate &gt; 10years . Diagnosis adenocarcinoma prostate confirm MSKCC review No prior treatment prostate cancer ECOG performance status 0 1 Prostate cancer clinical stage T1cT2a PSA &lt; 10ng/mL ( PSA level prompt prostate biopsy ) Prostate Size &lt; 60 cc transrectal ultrasound Medically unfit anesthesia Histology adenocarcinoma Men receive hormonal manipulation ( antiandrogens ; LHRH agonist ) within previous 6 month Men currently receive anticoagulant drug ( e.g . : Coumadin , warfarin ) Second Step Enrollment Repeat transrectal prostate biopsy must meet follow parameter : Minimum 12 biopsy core No Biopsy Gleason grade 4 5 Unilateral cancer ( rightsided leftsided , bilateral ) No 50 % cancer one biopsy core No 25 % core contain cancer Medically unfit anesthesia Histology adenocarcinoma Men receive hormonal manipulation ( antiandrogens ; LHRH agonist ) within previous 6 month Men currently receive anticoagulant drug ( e.g . : coumadin , warfarin )</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>focal cryotherapy</keyword>
	<keyword>low-risk prostate cancer</keyword>
</DOC>